PINNACLE COMPLETE ACETABULAR HIP SYSTEM

FDA Premarket Approval P090002

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the pinnacle complete acetabular hip system. This device is indicated for:the pinnacle complete acetabular hip system is a single use device intended for uncemented fixation. The pinnacle complete acetabular hip system is intended as a primary joint replacement prosthesis in total hip arthroplasty for skeletally mature patients suffering at least moderate pain in the hip joint from non-inflammatory degenerative jointdisease (nidjd) and its composite diagnoses of osteoarthritis (oa) or post-traumaticarthritis. Pinnacle complete acetabular hip system's inserts (pinnacle ultamet) are only intended for use with depuy's femoral and acetabular components having matching outer and inner diameters.

DevicePINNACLE COMPLETE ACETABULAR HIP SYSTEM
Generic NameProsthesis, Hip, Semi-constrained, Ceramic-on-metal Articulation
ApplicantDEPUY ORTHOPAEDICS, INC.
Date Received2009-02-17
Decision Date2011-06-13
Notice Date2011-06-15
PMAP090002
SupplementS
Product CodeOVO 
Docket Number11M-0470
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address DEPUY ORTHOPAEDICS, INC. p.o Box 988 700 Orthopaedic Drive warsaw, IN 46581-0988
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P090002Original Filing
S009 2013-03-12 135 Review Track For 30-day Notice
S008
S007 2012-11-28 Special (immediate Track)
S006 2012-10-25 30-day Notice
S005 2012-08-03 Special (immediate Track)
S004 2012-05-18 30-day Notice
S003 2012-03-27 30-day Notice
S002 2012-01-19 Real-time Process
S001 2011-09-07 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.